Israeli company developes first of its kind blood test to diagnose lung cancer

Israeli scientists from the Rehovot-based company Nucleix succeeded in developing a first of its kind blood test to diagnose lung cancer. The new test is able to diagnose the disease long before it spreads in More...

A new noninvasive monitoring test for bladder cancer

  The Israeli company Nucleix has developed a simple, inexpensive urine test to monitor bladder cancer, which has the highest lifetime treatment cost per patient of all types of cancer. Bladder EpiCheck More...